The Crypto Basic
Moderna (NASDAQ: MRNA) shares plunged more than 17% to $202.63 in Thursday's regular trading session after detailed Phase 3 results for its personalized melanoma vaccine, developed with Merck (NYSE: MRK),…
Related articles
-
Trezor Slashes Reseller Network After $93M Ledger Security Scare
Bitcoin.com Published 13.10.2026 16:25
-
Goldman Sachs Equity Trading Jumps 72% as JPMorgan Bond Desk Slips
BeInCrypto Published 14.10.2026 07:00
-
Best no KYC crypto card for USA: What buyers should check
Crypto.News Published 23.10.2026 12:30
-
XRP Hovers Near $1.46 as Short Positions Dominate and Nasdaq Listing Postponed
Blocknomi Published 07.10.2026 07:47
-
Bitcoin price recovers as Trump eases Iran fears, can BTC hold $82K?
Crypto.News Published 09.10.2026 06:56
-
BNB Foundation Completes 37th Quarterly BNB Token Burn
CryptoNewsZ Published 19.10.2026 14:01
-
Ledger wants customers to trust its new $849 device as criminals compromise existing wallets
CryptoSlate Published 16.10.2026 00:00
-
Binance Pool is closing. Where will its Bitcoin miners go?
Crypto.News Published 15.10.2026 10:48